Undesired off-target effects can hamper the use of CRISPR-Cas9 in therapeutic applications. Here the authors use a directed evolution approach to develop Sniper-Cas9 which combines high specificity with no loss of on-target activity.
- Jungjoon K. Lee
- Euihwan Jeong
- Jin-Soo Kim